Below is a comprehensive archive of press releases from MSF USA. Use the options in the boxes below to filter results based on your preferences.

Country/Region

Topic

This week, MSF warned the Global Fund of the consequences of a new pricing intitative that could result in middle-income countries paying higher prices for medicines.

More >

NEW YORK—A massive humanitarian crisis in the Central African Republic (CAR) is growing even more severe, as fighting and threats against civilians near the town of Bouca have driven hundreds more people to flee, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) said today.

More >

In several countries where MSF works—such DRC, Guinea, Central African Republic, Nigeria, South Sudan and Myanmar—timely treatment remains out of reach for the majority of people who need it.

More >

Hundreds of refugees are living in appalling conditions in Bulgarian reception centers where there is a disastrous lack of medical care.

More >

As TPP negotiators gather to meet for the first time since the intellectual property chapter of the secret trade agreement was leaked last week, MSF is urging countries to stand strongly against the US government’s attack on access to affordable medicines.

More >

PARIS/NEW YORK—Without a new approach to developing and pricing new tuberculosis (TB) medicines, the global TB response will be unable to deliver the new treatment combinations needed to close the deadly treatment gap for drug-resistant tuberculosis (DR-TB), warned the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) at the Union World Conference on Lung Health in Paris.

More >

Several key policy changes are urgently needed at the GAVI Alliance to help reach the 22.6 million children not benefitting from vaccination globally.

More >

More than 100,000 people have fled the district of Al Safira in Syria's Aleppo province, where dozens of people have been killed and hundreds wounded in shelling and bombings.

More >

This continued ‘fatal imbalance’ in medical R&D points to the urgent need to develop and deliver groundbreaking new treatments for the world's poorest and most neglected patients.

More >

"The global failure to scale-up diagnosis and treatment for drug-resistant TB is being paid for in lives."

More >

Pages